Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Terminated1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04081688Phase 1Terminated
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Refractory Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
PrincipalinvestigatorStart date: 2019-09-11
NCT03257163Phase 2Active Not Recruiting
Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer
Epstein-Barr Virus PositiveGastric AdenocarcinomaMismatch Repair Protein Deficiency+8 more
PrincipalinvestigatorStart date: 2017-09-29
NCT03228147Not ApplicableCompleted
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
EsophagitisMalignant NeoplasmMucositis
PrincipalinvestigatorStart date: 2017-07-25

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jyoti Malhotra

Rutgers Cancer Institute of New Jersey

Related
4 trials

Shared therapeutic areas:

Refractory Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)Rutgers, The State University of New Jersey
Collaborated on 1 trial
Similarity Score24%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

CancerStage IV Lung Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

CancerStage IV Lung Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

Emily Y Chew, M.D.

National Eye Institute (NEI)

Related
17 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04081688Phase 1PrincipalInvestigator

Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC

Refractory Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
Terminated
NCT03257163Phase 2PrincipalInvestigator

Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

Epstein-Barr Virus PositiveGastric AdenocarcinomaMismatch Repair Protein Deficiency+8 more
Active Not Recruiting
NCT03228147Not ApplicablePrincipalInvestigator

Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment

EsophagitisMalignant NeoplasmMucositis
Completed

All 3 trials loaded